Nasal postbiotic therapy restores NALT architecture and enhances respiratory innate immunity in protein-malnourished mice

Abstract

BackgroundMalnutrition compromises mucosal immunity, especially in the respiratory tract, increasing susceptibility to pathogens like Streptococcus pneumoniae. This study assessed whether nasal administration of Lacticaseibacillus rhamnosus CRL1505 or its peptidoglycan could promote the recovery of nasopharynx-associated lymphoid tissue (NALT) structure and functionality, thereby enhancing resistance to S. pneumoniae infection in protein-malnourished mice. MethodsMale Swiss albino mice were fed to a protein-free diet to induce malnutrition, followed by nutritional repletion with or without nasal supplementation of CRL1505 or its peptidoglycan. Resistance to S. pneumoniae infection, NALT architecture, immune cell composition in NALT and regional lymph nodes, and nasal cytokine production were evaluated. ResultsProtein deficiency caused marked NALT atrophy, immune cell depletion, and heightened susceptibility to S. pneumoniae. Nutritional repletion alone partially reversed these effects. In contrast, nasal supplementation with CRL1505 or its postbiotic fully restored NALT structure and cellularity, normalized lymphoid and myeloid populations, and reduced pathogen burden. Both treatments increased B and T lymphocytes, immature B cells, dendritic cells, and macrophages. The postbiotic also enhanced MHCII expression and balanced neutrophil-like Gr-1 cells. Notably, immune enhancement was evident even before infection, indicating a mucosal priming effect. Cytokine levels in nasal fluids remained largely unchanged. ConclusionsNasal delivery of L. rhamnosus CRL1505 or its postbiotic effectively reestablished NALT integrity and mucosal immunity in malnourished mice, providing significant protection against respiratory pathogens. These findings support the development of nasal immunobiotic formulations as non-invasive interventions to bolster respiratory defenses in immunocompromised hosts.